The VHL Alliance has published suggested surveillance guidelines approved by the VHLA Clinical Advisory Council regarding testing for individuals at risk for von Hippel-Lindau disease (VHL) who do not yet have symptoms or those who are known to have VHL but do not yet symptoms in a particular area. The unaffected organs should still be screened. Read the screening guidelines. View a list of organs that can be impacted by VHL.
News from NORD
VHL Alliance Publishes Suggested VHL Surveillance Guidelines
Publish date: November 7, 2016
